Optic Nerve Sheath Diameter in Desflurane Anesthesia for Laparoscopic Cholecystectomy
Data Collection
Collected from today forward - ProspectiveCohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 1, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding how different rates of desflurane anesthesia impact the optic nerve sheath diameter during laparoscopic cholecystectomy surgeries. Desflurane is a common anesthetic agent that can mildly increase blood flow and pressure in the brain. While these changes are generally well-tolerated, they need to be closely monitored to prevent complications. The study involves patients aged 18-65 years who are scheduled for elective laparoscopic cholecystectomy under general anesthesia. The research aims to improve the understanding of how anesthesia can be safely administered during such surgeries, potentially enhancing patient care and reducing risks associated with anesthesia. During the study, patients will be divided into two groups based on the fresh gas flow rate used during their anesthesia: 1 L/min or 3 L/min. The optic nerve sheath diameter will be measured using ultrasonography before, during, and after the surgery. These measurements help evaluate changes in intracranial pressure. Patients' heart rate, blood pressure, oxygen levels, and other vital signs will be closely monitored throughout the procedure. The study also records any instances of nausea, vomiting, or shivering in the recovery phase. The results of this study will provide valuable insights into the effects of different anesthesia flow rates on intracranial pressure, potentially guiding future anesthesia practices.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.64 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, Turkey (Türkiye)Open Fatih Sultan Mehmet Training and Research Hospital in Google Maps